Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Genetics and Genomics›Ribotyping
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Ribotyping

Genetics and Genomics · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

Restriction fragment length polymorphism analysis of rRNA genes that is used for differentiating between species or strains.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (939 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Restriction fragment length polymorphism analysis of rRNA genes that is used for differentiating between species or strains.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Ribotype; Ribotypes; Riboprinting; Riboprint; Riboprints.

Where it fits in the MeSH classification

Broader topics
Bacterial Typing Techniques; DNA Fingerprinting

Related concepts

  • Restriction Fragment Length Polymorphism

Research landscape

PubMed indexes 2,540 records tagged with the MeSH heading “Ribotyping” (counts retrieved 2026-10-29). 367 of them (14.4%) were published from 2020 onward, and the busiest period so far is 2000-2009 with 1,104 records.

Reviews account for 104 records (4.1%) and meta-analyses for 3. Randomized controlled trials number 17 (0.7%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 1,104 records; 2010-2019: 1,094 records; 2020 onward: 367 records0through 19991,1042000-20091,0942010-20193672020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-20091,104
2010-20191,094
2020 onward367
Share of records by publication typeReviews: 4.1 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 0.7 percentReviews4.1% (104)Meta-analyses0.1% (3)Randomized controlled trials0.7% (17)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 2,540 PubMed records
TypeRecordsShare
Reviews1044.1%
Meta-analyses30.1%
Randomized controlled trials170.7%

Method: PubMed query "Ribotyping"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in genetics and genomics

Genetic findings vary widely in strength. A variant linked to a condition in one study may not replicate in other ancestries, and most common variants have small effects that are meaningful only in aggregate. Studies of rare, high-impact variants can support strong causal claims about a gene, while association studies describe statistical links that need functional and independent replication. Check the sample size, the ancestry of participants, whether results were replicated, and whether a laboratory or clinical outcome was actually measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile
Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al.
2015Research article
Design not recorded in structured metadata
180cc0
PMID 25679978 · DOI · PMC4332677
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping
Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, et al.
2008Research article
Design not recorded in structured metadata
177cc by
PMID 18927415 · DOI · PMC2884938
Clostridium difficile PCR ribotypes in calves, Canada
Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, et al.
2006Research article
Design not recorded in structured metadata
172cc by
PMID 17283624 · DOI · PMC3372327
Acquisition of a gene cluster in Clostridioides difficile PCR ribotype 023 strains enables xylitol utilization
Wozniak KJ, Pan L, Zhu D, Corver J, Kuijper EJ, Smits WK, et al.
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42461050 · DOI · PMC13508786

Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile [1]

Research article Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al. · · 2015 · cited 180 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
PCR-ribotyping has been adopted in many laboratories as the method of choice for C.
Closing excerpt
difficile surveillance programs.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (220 words)

PCR-ribotyping has been adopted in many laboratories as the method of choice for C. difficile typing and surveillance. However, issues with the conventional agarose gel-based technique, including inter-laboratory variation and interpretation of banding patterns have impeded progress. The method has recently been adapted to incorporate high-resolution capillary gel-based electrophoresis (CE-ribotyping), so improving discrimination, accuracy and reproducibility. However, reports to date have all represented single-centre studies and inter-laboratory variability has not been formally measured or assessed. Here, we achieved in a multi-centre setting a high level of reproducibility, accuracy and portability associated with a consensus CE-ribotyping protocol. Local databases were built at four participating laboratories using a distributed set of 70 known PCR-ribotypes. A panel of 50 isolates and 60 electronic profiles (blinded and randomized) were distributed to each testing centre for PCR-ribotype identification based on local databases generated using the standard set of 70 PCR-ribotypes, and the performance of the consensus protocol assessed. A maximum standard deviation of only ±3.8bp was recorded in individual fragment sizes, and PCR-ribotypes from 98.2% of anonymised strains were successfully discriminated across four ribotyping centres spanning Europe and North America (98.8% after analysing discrepancies). Consensus CE-ribotyping increases comparability of typing data between centres and thereby facilitates the rapid and accurate transfer of standardized typing data to support future national and international C. difficile surveillance programs.

Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 25679978 · DOI · PMC4332677

Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping [2]

Research article Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, et al. · · 2008 · cited 177 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
We have developed a Clostridium difficile PCR ribotyping method based on capillary gel electrophoresis and have compared it with conventional PCR ribotyping.
Closing excerpt
We consider capillary gel electrophoresis-based PCR ribotyping to be a way of overcoming the problems associated with inter-laboratory comparisons of typing results, while at the same time substantially diminishing the hands-on time for PCR ribotyping.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (197 words)

We have developed a Clostridium difficile PCR ribotyping method based on capillary gel electrophoresis and have compared it with conventional PCR ribotyping. A total of 146 C. difficile isolates were studied: five isolates were reference strains (PCR ribotypes 001, 014, 017, 027 and 053); 141 were clinical isolates comprising 39 Austrian PCR ribotypes collected in the period 2006-2007 at 25 Austrian healthcare facilities. Capillary gel electrophoresis yielded up to 11 fragments per isolate and 47 ribotype patterns. All but one of the five PCR ribotypes of reference strains were clearly reflected in the chromatograms of capillary-based typing. Capillary gel electrophoresis divided 24 isolates belonging to PCR ribotype type 014 into seven subgroups, whereas subtyping the same isolates using multiple-locus variable-number tandem-repeat analysis yielded three unrelated subgroups, without obvious correlation to sr subgroups. Using a web-based software program (http://webribo.ages.at), we were able to correctly identify these 014 isolates by simply allocating the seven subgroup patterns to one ribotype, i.e. to PCR ribotype 014. We consider capillary gel electrophoresis-based PCR ribotyping to be a way of overcoming the problems associated with inter-laboratory comparisons of typing results, while at the same time substantially diminishing the hands-on time for PCR ribotyping.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 18927415 · DOI · PMC2884938

Clostridium difficile PCR ribotypes in calves, Canada [3]

Research article Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, et al. · · 2006 · cited 172 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
We investigated Clostridium difficile in calves and the similarity between bovine and human C.
Closing excerpt
difficile for humans.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (159 words)

We investigated Clostridium difficile in calves and the similarity between bovine and human C. difficile PCR ribotypes by conducting a case-control study of calves from 102 dairy farms in Canada. Fecal samples from 144 calves with diarrhea and 134 control calves were cultured for C. difficile and tested with an ELISA for C. difficile toxins A and B. C. difficile was isolated from 31 of 278 calves: 11 (7.6%) of 144 with diarrhea and 20 (14.9%) of 134 controls (p = 0.009). Toxins were detected in calf feces from 58 (56.8%) of 102 farms, 57 (39.6%) of 144 calves with diarrhea, and 28 (20.9%) of 134 controls (p = 0.0002). PCR ribotyping of 31 isolates showed 8 distinct patterns; 7 have been identified in humans, 2 of which have been associated with outbreaks of severe disease (PCR types 017 and 027). C. difficile may be associated with calf diarrhea, and cattle may be reservoirs of C. difficile for humans.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 17283624 · DOI · PMC3372327

Acquisition of a gene cluster in Clostridioides difficile PCR ribotype 023 strains enables xylitol utilization [4]

Research article Wozniak KJ, Pan L, Zhu D, Corver J, Kuijper EJ, Smits WK, et al. · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Hundreds of ribotypes of the gastrointestinal pathogen Clostridioides difficile have emerged over the last three decades, yet the factors driving their emergence are poorly understood.
Closing excerpt
difficile will improve our understanding of colonization and hypervirulence.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (363 words)

Hundreds of ribotypes of the gastrointestinal pathogen Clostridioides difficile have emerged over the last three decades, yet the factors driving their emergence are poorly understood. Recently, there has been an increase in infections caused by PCR ribotype 023 (RT023) strains in Europe. We profiled the growth of seven RT023 strains in 190 unique carbon sources and found they were able to grow in xylitol, a sugar alcohol used as a food additive in humans and animals. Other ribotypes of C. difficile tested (n = 19) displayed little to no growth in 0.5% xylitol and were growth-inhibited in higher concentrations of xylitol. Genome sequencing identified that RT023 strains acquired a putative xylitol dehydrogenase (xdh) gene in a mobile genetic element (MGE) that is absent from other C. difficile ribotypes. We created a deletion of xdh in the RT023 strain PRB1128 and observed poor growth in xylitol, indicating that the xdh is necessary for xylitol utilization. Complementation of the xdh mutant with a plasmid-based inducible copy of the xdh gene restored growth in xylitol. We performed competition assays in minibioreactor arrays (MBRAs) and observed that PRB1128 outcompeted the non-xylitol-utilizing strain CD2015 (RT027) in the presence of xylitol. These data support that the xdh gene within RT023 strains provides a fitness benefit for growth in xylitol. Interestingly, the chromosomal locus where the MGE inserted appears to be a hotspot for genetic insertions across clades of C. difficile. Together, this work improves our understanding of the molecular basis for niche adaptation of C. difficile.IMPORTANCEGenetic factors aiding in the emergence of the opportunistic pathogen Clostridioides difficile are poorly understood. Infections with clade 3 (PCR ribotype 023) strains causing severe disease have increased since 2008. Here, we show RT023 strains have the unique ability to utilize xylitol, a sugar alcohol used as a food additive in humans and animals, due to the presence of a xylitol dehydrogenase (xdh) gene within a mobile genetic element (MGE). This xylitol utilization ability confers a fitness benefit in competition against other C. difficile ribotypes, as well as in a fecal community in vitro. Research investigating the underlying genetic factors driving the physiology of C. difficile will improve our understanding of colonization and hypervirulence.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42461050 · DOI · PMC13508786

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques [5]
    Amann R, Fuchs BM · Nat Rev Microbiol · 2008 · cited 459 times (Europe PMC)
  • Research article Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread [6]
    Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV · Lancet Infect Dis · 2010 · cited 151 times (Europe PMC)
  • Research article Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies [7]
    Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M · J Hosp Infect · 2018 · cited 99 times (Europe PMC)
  • Research article The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move [8]
    Valiente E, Cairns MD, Wren BW · Clin Microbiol Infect · 2014 · cited 90 times (Europe PMC)
  • Research article Phylogenetic analysis and the evolution of the 18S rRNA gene typing system of Acanthamoeba [9]
    Fuerst PA, Booton GC, Crary M · J Eukaryot Microbiol · 2015 · cited 82 times (Europe PMC)
  • Research article Challenges for standardization of Clostridium difficile typing methods [10]
    Huber CA, Foster NF, Riley TV, Paterson DL · J Clin Microbiol · 2013 · cited 46 times (Europe PMC)

References

  1. Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al.. Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. . 2015. PMID 25679978 · DOI · PMC4332677
  2. Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, et al.. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. . 2008. PMID 18927415 · DOI · PMC2884938
  3. Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, et al.. Clostridium difficile PCR ribotypes in calves, Canada. . 2006. PMID 17283624 · DOI · PMC3372327
  4. Wozniak KJ, Pan L, Zhu D, Corver J, Kuijper EJ, Smits WK, et al.. Acquisition of a gene cluster in Clostridioides difficile PCR ribotype 023 strains enables xylitol utilization. . 2026. PMID 42461050 · DOI · PMC13508786
  5. Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Microbiol. 2008. PMID 18414500 · DOI
  6. Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis. 2010. PMID 20510280 · DOI · PMC7185771
  7. Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect. 2018. PMID 29410012 · DOI
  8. Valiente E, Cairns MD, Wren BW. The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move. Clin Microbiol Infect. 2014. PMID 24621128 · DOI
  9. Fuerst PA, Booton GC, Crary M. Phylogenetic analysis and the evolution of the 18S rRNA gene typing system of Acanthamoeba. J Eukaryot Microbiol. 2015. PMID 25284310 · DOI
  10. Huber CA, Foster NF, Riley TV, Paterson DL. Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol. 2013. PMID 23784128 · DOI · PMC3754675

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Molecular TypingGenetics and Genomics
  • Multilocus Sequence TypingGenetics and Genomics
  • DNA FingerprintingGenetics and Genomics
  • Cytogenetic AnalysisGenetics and Genomics
  • Genetic TestingGenetics and Genomics
  • In Situ HybridizationGenetics and Genomics

All 95 articles in Genetics and Genomics →

At a glance

2,540
PubMed records on this heading
14%
published since 2020
104
review articles
17
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Molecular TypingGenetics and Genomics
  • Multilocus Sequence TypingGenetics and Genomics
  • DNA FingerprintingGenetics and Genomics
  • Cytogenetic AnalysisGenetics and Genomics
  • Genetic TestingGenetics and Genomics

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support